Coeptis Therapeutics (COEP) Stocktwits Mentions Statistics 2025

1290%

1W 174.5% 1M 87% 3M 32.8%

Est. daily mentions on Stocktwits.

Similar companies

Company		Stocktwits Mentions
	Amgen AMGN	20 4.8%
	Gilead Sciences GILD	135 0.7%
	Catalyst Pharmaceuticals CPRX	11 0%
	Inovio Pharmaceuticals INO	255 5.8%
	Anavex Life Sciences AVXL	331 2.5%

Month over Month

Est. daily mentions on Stocktwits.

Mar 2025	95	3.7%
Feb 2025	99	61.3%
Jan 2025	256	211.5%
Dec 2024	82	8122.6%
Nov 2024	1

How often is Coeptis Therapeutics mentioned on StockTwits?

Coeptis Therapeutics was mentioned an estimated 129 times in discussions on StockTwits yesterday.

Analyzing Stocktwits Mentions, how is Coeptis Therapeutics performing compared to its industry peers?

Coeptis Therapeutics underperforms its industry peers when it comes to Stocktwits Mentions, ranking in the 8th percentile.

What does a high frequency of StockTwits mentions indicate for Coeptis Therapeutics' market sentiment?

A high frequency of mentions on StockTwits for Coeptis Therapeutics could indicate strong market interest or sentiment towards the company. It often reflects the trading community's engagement with Coeptis Therapeutics' stock, potentially signaling bullish or bearish trends based on the context of the discussions.

How often does AltIndex update information on Coeptis Therapeutics' mentions on StockTwits?

AltIndex updates the data on Coeptis Therapeutics' mentions on StockTwits daily. This frequent update schedule ensures that investors have access to the most current insights into market sentiment and discussion dynamics related to Coeptis Therapeutics' on the platform.

About Us

AltIndex revolutionizes investing with advanced alternative data analytics, smart insights, and stock alerts, presented in an easy-to-use dashboard powered by comprehensive company data from across the internet.

Legal Disclaimer
The information provided by AltIndex is solely for informational purposes and not a substitute for professional financial advice. Investing in financial markets carries inherent risks, and past performance doesn't guarantee future results. It's crucial to do your research, consult with financial experts, and align your financial objectives and risk tolerance before investing. AltIndex creators and operators are not liable for any financial losses incurred from using this information. Users should exercise caution, seek professional advice, and be prepared for the risks involved in trading and investing in financial assets, only investing what they can afford to lose. The information in this application, derived from publicly available data, is believed to be reliable but may not always be accurate or current. Users should verify information independently and not solely rely on this application for financial decisions. By using AltIndex, you acknowledge that it doesn't offer financial advice and agree to consult a qualified financial advisor before making investment decisions.